Cyclosporine

CEQUA, Gengraf, Neoral, RESTASIS, Restasis MultiDose, Sandimmune, Verkazia

Calcineurin Inhibitor Immunosuppressant

NADAC/unit $0.3102

No Shortage Tier 1: 184.2% PA Req: 786.9% 15 Manufacturers 28 ANDAs

VEVYE indicated for the treatment of the signs and symptoms of dry eye disease.

vs. brand CEQUA: Generic saves up to 97% per unit

Covered Lives

Market Intelligence

2023-09-27 Class III Recall: SUN PHARMACEUTICAL INDUSTRIES INC

Generic Manufacturers

ABBVIE INCAMNEAL PHARMACEUTICALS LLCAPOTEX INCDEVA HOLDING ASDR REDDYS LABORATORIES SAHARROW EYE LLCHIKMA PHARMACEUTICALS USA INCIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USAMYLAN PHARMACEUTICALS INCNOVARTIS PHARMACEUTICALS CORPONESOURCE SPECIALTY PTE LTDPADAGIS US LLCQILU PHARMACEUTICAL CO LTDSANDOZ INCSAPTALIS PHARMACEUTICALS LLCSUN PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCTWI PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Cyclosporine drfinder.aiFind doctors who prescribe Cyclosporine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Cyclosporine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.